Cargando…

The effect of ketamine on psychopathology and implications for understanding schizophrenia and its therapeutic use: a meta-analysis

AIMS: To conduct a meta-analysis of the effect of ketamine on psychopathology in healthy volunteers and patients with schizophrenia, and the experimental factors affecting this. BACKGROUND: Ketamine is increasingly used to treat depression and other psychiatric disorders but can induce schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beck, Katherine, Hindley, Guy, Borgan, Faith, Ginestet, Cedric, McCutcheon, Robert, Brugger, Stefan, Driesen, Naomi, Ranganathan, Mohini, D'Souza, Deepak, Taylor, Matthew, Krystal, John, Howes, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771247/ http://dx.doi.org/10.1192/bjo.2021.634

Ejemplares similares

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis
por: Beck, Katherine, et al.
Publicado: (2020)

Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis
por: Hindley, Guy, et al.
Publicado: (2020)

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2020)

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species
por: Borgan, Faith, et al.
Publicado: (2019)

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019)

Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans
por: Driesen, Naomi R., et al.
Publicado: (2013)

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
por: Howes, O D, et al.
Publicado: (2017)

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
por: McCutcheon, Robert, et al.
Publicado: (2018)

Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study
por: Borgan, Faith R., et al.
Publicado: (2019)

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Comparative Effects of Antipsychotics on Metabolic and Endocrine Function in Children and Young People With Schizophrenia: A Systematic Review and Network Meta-Analysis
por: Rogdaki, Maria, et al.
Publicado: (2023)

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
por: Abdallah, Chadi G., et al.
Publicado: (2020)

F18. IS SCHIZOPHRENIA A MULTI-SYSTEM DISORDER? CONSIDERING NEUROLOGICAL, IMMUNE, CARDIOMETABOLIC, AND ENDOCRINE ALTERATIONS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls
por: McCutcheon, Robert A., et al.
Publicado: (2021)

T79. BALANCING EFFECTS WITH SIDE-EFFECTS: EXAMINING COMPARATIVE METABOLIC CONSEQUENCES OF 18 ANTIPSYCHOTICS IN TREATMENT OF SCHIZOPHRENIA USING NETWORK META-ANALYSIS
por: Pillinger, Toby, et al.
Publicado: (2020)

White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis
por: Carreira Figueiredo, Inês, et al.
Publicado: (2022)

Effects of Nicotine on the Neurophysiological and Behavioral Effects of Ketamine in Humans
por: Mathalon, Daniel H., et al.
Publicado: (2014)

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
por: McCutcheon, R., et al.
Publicado: (2017)

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
por: Jauhar, Sameer, et al.
Publicado: (2018)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

Psychopathology of Schizophrenia
por: Stengel, E.
Publicado: (1966)

T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
por: Pillinger, Toby, et al.
Publicado: (2019)

The Efficacy and Heterogeneity of Antipsychotic Response in Schizophrenia: A Meta-analysis
por: McCutcheon, Robert A., et al.
Publicado: (2021)

The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A (1)H-MRS study in first-episode psychosis patients
por: Zahid, Uzma, et al.
Publicado: (2022)

INSIGHT, PSYCHOPATHOLOGY & SCHIZOPHRENIA
por: Armstrongh, K.P. Lincoln, et al.
Publicado: (2002)

INSIGHT AND PSYCHOPATHOLOGY IN SCHIZOPHRENIA
por: Tharyan, Anna, et al.
Publicado: (2000)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

Understanding incomprehensibility: Misgivings and potentials of the phenomenological psychopathology of schizophrenia
por: Wendler, Hannes, et al.
Publicado: (2023)

Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2023)

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
por: McCutcheon, Robert A., et al.
Publicado: (2023)

17.2 EFFICACY OF CANNABIDIOL IN THE TREATMENT OF EARLY PSYCHOSIS.
por: Ranganathan, Mohini, et al.
Publicado: (2018)

The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An (18)F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
por: Shin, Sangho, et al.
Publicado: (2022)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Connectivity, Pharmacology, and Computation: Toward a Mechanistic Understanding of Neural System Dysfunction in Schizophrenia
por: Anticevic, Alan, et al.
Publicado: (2013)

Correction: Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
por: McCutcheon, Robert A., et al.
Publicado: (2023)

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_alef60blj79n8ted5rkl11588a